Veterinary Medicines

Rismavac Comp. Vet. koncentrat og solvens til injektionsvæske, suspension

Authorised
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
Download as PDF

Product identification

Medicine name:
Rismavac Comp. Vet. koncentrat og solvens til injektionsvæske, suspension
Rismavac Comp. Vet. koncentrat og solvens til injektionsvæske, suspension
Active substance:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
Target species:
  • Poultry
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey herpesvirus, strain FC-126 (cell-associated), Live
    1000.00
    plaque forming unit
    /
    1.00
    Dose
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
    1000.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Poultry
  • Subcutaneous use
    • Poultry
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 19466
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish ( VET, KONCENTRAT OG SOLVENS TIL INJEKTIONSVÆSKE, SUSPENSION)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."